Cargando…
Life impact of VA‐ECMO due to primary graft dysfunction in patients after orthotopic heart transplantation
AIMS: Primary graft dysfunction (PGD) is a feared complication after heart transplantation (HTX). HTX patients frequently receive veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) until graft recovery. Long‐term mortality of patients weaned from VA‐ECMO after HTX is comparable with non‐ECM...
Autores principales: | M'Pembele, René, Roth, Sebastian, Stroda, Alexandra, Buse, Giovanna Lurati, Sixt, Stephan U., Westenfeld, Ralf, Polzin, Amin, Rellecke, Philipp, Tudorache, Igor, Hollmann, Markus W., Aubin, Hug, Akhyari, Payam, Lichtenberg, Artur, Huhn, Ragnar, Boeken, Udo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788039/ https://www.ncbi.nlm.nih.gov/pubmed/34734490 http://dx.doi.org/10.1002/ehf2.13686 |
Ejemplares similares
-
Fibrinogen–Albumin-Ratio is an independent predictor of thromboembolic complications in patients undergoing VA-ECMO
por: Roth, Sebastian, et al.
Publicado: (2021) -
Risk Factors for Acute Kidney Injury Requiring Renal Replacement Therapy after Orthotopic Heart Transplantation in Patients with Preserved Renal Function
por: M‘Pembele, René, et al.
Publicado: (2021) -
Neutrophil-lymphoycyte-ratio, platelet-lymphocyte-ratio and procalcitonin for early assessment of prognosis in patients undergoing VA-ECMO
por: Roth, Sebastian, et al.
Publicado: (2022) -
Impact of Cardiopulmonary Resuscitation of Donors on Days Alive and Out of Hospital after Orthotopic Heart Transplantation
por: Roth, Sebastian, et al.
Publicado: (2022) -
Days alive and out of hospital after left ventricular assist device implantation
por: Roth, Sebastian, et al.
Publicado: (2022)